0001596783-23-000168.txt : 20231102
0001596783-23-000168.hdr.sgml : 20231102
20231102211701
ACCESSION NUMBER: 0001596783-23-000168
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20231025
FILED AS OF DATE: 20231102
DATE AS OF CHANGE: 20231102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McErlane David
CENTRAL INDEX KEY: 0001999358
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36587
FILM NUMBER: 231374275
MAIL ADDRESS:
STREET 1: C/O CATALENT, INC.
STREET 2: 14 SCHOOLHOUSE ROAD
CITY: SOMERSET
STATE: NJ
ZIP: 08873
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Catalent, Inc.
CENTRAL INDEX KEY: 0001596783
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208737688
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 14 SCHOOLHOUSE ROAD
CITY: SOMERSET
STATE: NJ
ZIP: 08873
BUSINESS PHONE: (732) 537-6200
MAIL ADDRESS:
STREET 1: 14 SCHOOLHOUSE ROAD
CITY: SOMERSET
STATE: NJ
ZIP: 08873
FORMER COMPANY:
FORMER CONFORMED NAME: PTS Holdings Corp.
DATE OF NAME CHANGE: 20140113
3
1
wk-form3_1698974210.xml
FORM 3
X0206
3
2023-10-25
0
0001596783
Catalent, Inc.
CTLT
0001999358
McErlane David
C/O CATALENT. INC.
14 SCHOOLHOUSE ROAD
SOMERSET
NJ
08873
0
1
0
0
Group President, Biologics
Common Stock
19552
D
Options to purchase Common Stock
45.79
2033-09-25
Common Stock
14740
D
Restricted stock units, each representing the right to receive one share of Issuer's common stock as of the date of vesting, which is scheduled to occur in three equal annual installments beginning on September 25, 2024.
The options vest and become exercisable in four equal annual installments beginning on September 25, 2024.
/s/ Amy Fallone, attorney-in-fact
2023-11-02
EX-24.POA
2
poa_mcerlane.txt
EX-24.POA
POWER OF ATTORNEY
Know all by these presents that the undersigned does hereby make, constitute,
and appoint each of Amy Fallone and Joseph Ferraro, or either of them, as a true
and lawful attorney-in-fact of the undersigned, with full powers of substitution
and revocation, for and in the name, place, and stead of the undersigned (in the
undersigned's individual capacity) to execute and deliver such forms that the
undersigned may be required to file with the U.S. Securities and Exchange
Commission as a result of the undersigned's ownership of or transactions in
securities of Catalent, Inc. (i) pursuant to Section 16(a) of the Securities
Exchange Act of 1934, as amended ("Section 16"), including without limitation
statements on Form 3, Form 4, and Form 5, and any amendments thereto; and (ii)
in connection with any applications for EDGAR access codes, including without
limitation the Form ID. This Power of Attorney shall remain in full force and
effect until the undersigned is no longer required to make filings pursuant to
Section 16 with regard to the undersigned's ownership of or transactions in
securities of Catalent, Inc., unless earlier revoked in writing. The undersigned
acknowledges that Amy Fallone and Joseph Ferraro are not assuming any of the
undersigned's responsibilities to comply with Section 16.
/s/ David McErlane
----------------------------------
David McErlane
Date: October 31, 2023